• Something wrong with this record ?

Labeling of apoptotic JURL-MK1 cells by fluorescent caspase-3 inhibitor FAM-DEVD-fmk occurs mainly at site(s) different from caspase-3 active site

Kuzelová K., Grebenová D., Hrkal Z.

. 2007 ; 71 (8) : 605-611.

Language English Country United States

E-resources Online

NLK Free Medical Journals from 2003 to 1 year ago
Wiley Online Library (archiv) from 1980-01-01 to 2012-12-31
Wiley Free Content from 2003 to 1 year ago

BACKGROUND: Fluorochrome-labeled inhibitors of caspases (FLICA) have been designed as an alternative tool for the detection of caspase activation in whole cells. They should label the active site of the corresponding caspase through a covalent attachment to the reactive cysteine residue. METHODS: One of the FLICAs, FAM-DEVD-fmk, was used to monitor apoptosis progression in leukemic JURL-MK1 cells by means of flow cytometry. The effects of unlabeled caspase inhibitors z-DEVD-fmk and z-VAD-fmk on FLICA staining were analyzed to evaluate the contribution of caspase-bound FLICA to the fluorescent signal. Covalent binding of inhibitors to caspase-3 subunit was revealed by Western blotting. RESULTS: Although the unlabeled inhibitors irreversibly bind to caspase-3, completely inhibit its activity, and prevent FLICA binding to caspase-3 even at concentrations lower than 5 muM, they have no effect on FLICA staining of apoptotic cells. CONCLUSIONS: Fluorescent signal of FLICA is characteristic for apoptotic cells but originates mainly from yet unspecified site(s) that differ from the caspase active site. This finding puts in doubt the specificity of staining by various FLICAs with regard to individual caspases and shows the need for an extreme care in the interpretation of data obtained using these labels. Copyright 2007 International Society for Analytical Cytology.

000      
00000naa 2200000 a 4500
001      
bmc10001075
003      
CZ-PrNML
005      
20120910174114.0
008      
100118s2007 xxu e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kuželová, Kateřina $7 xx0115456
245    10
$a Labeling of apoptotic JURL-MK1 cells by fluorescent caspase-3 inhibitor FAM-DEVD-fmk occurs mainly at site(s) different from caspase-3 active site / $c Kuzelová K., Grebenová D., Hrkal Z.
314    __
$a Department of Cellular Biochemistry, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic. kuzel@uhkt.cz
520    9_
$a BACKGROUND: Fluorochrome-labeled inhibitors of caspases (FLICA) have been designed as an alternative tool for the detection of caspase activation in whole cells. They should label the active site of the corresponding caspase through a covalent attachment to the reactive cysteine residue. METHODS: One of the FLICAs, FAM-DEVD-fmk, was used to monitor apoptosis progression in leukemic JURL-MK1 cells by means of flow cytometry. The effects of unlabeled caspase inhibitors z-DEVD-fmk and z-VAD-fmk on FLICA staining were analyzed to evaluate the contribution of caspase-bound FLICA to the fluorescent signal. Covalent binding of inhibitors to caspase-3 subunit was revealed by Western blotting. RESULTS: Although the unlabeled inhibitors irreversibly bind to caspase-3, completely inhibit its activity, and prevent FLICA binding to caspase-3 even at concentrations lower than 5 muM, they have no effect on FLICA staining of apoptotic cells. CONCLUSIONS: Fluorescent signal of FLICA is characteristic for apoptotic cells but originates mainly from yet unspecified site(s) that differ from the caspase active site. This finding puts in doubt the specificity of staining by various FLICAs with regard to individual caspases and shows the need for an extreme care in the interpretation of data obtained using these labels. Copyright 2007 International Society for Analytical Cytology.
650    _2
$a financování organizované $7 D005381
650    _2
$a chloromethylketony aminokyselin $x analýza $x farmakologie $x metabolismus $7 D000590
650    _2
$a apoptóza $7 D017209
650    _2
$a vazebná místa $7 D001665
650    _2
$a kaspasa 3 $7 D053148
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a průtoková cytometrie $7 D005434
650    _2
$a fluorescenční barviva $x analýza $x metabolismus $7 D005456
650    _2
$a lidé $7 D006801
650    _2
$a kinetika $7 D007700
650    _2
$a propidium $7 D011419
650    _2
$a posttranslační úpravy proteinů $x účinky léků $7 D011499
650    _2
$a podjednotky proteinů $x metabolismus $7 D021122
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a barvení a značení $7 D013194
650    _2
$a substrátová specifita $7 D013379
650    _2
$a inhibitory kaspas $7 D061945
700    1_
$a Grebeňová, Dana $7 xx0115458
700    1_
$a Hrkal, Zbyněk, $d 1934- $7 xx0059987
773    0_
$w MED00013935 $t Cytometry. Part A $g Roč. 71, č. 8 (2007), s. 605-611 $x 1552-4922
910    __
$a ABA008 $b x $y 8
990    __
$a 20100114083259 $b ABA008
991    __
$a 20120910174308 $b ABA008
999    __
$a ok $b bmc $g 704723 $s 567289
BAS    __
$a 3
BMC    __
$a 2007 $b 71 $c 8 $d 605-611 $i 1552-4922 $m Cytometry. Part A $x MED00013935
LZP    __
$a 2010-b1/vtme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...